Johnson & Johnson Recalls Infant Tylenol

Jeannette Y. Wick, RPh, MBA, FASCP
Published Online: Wednesday, March 14, 2012
Follow Pharmacy_Times:
The pharmaceutical giant’s McNeil Consumer Healthcare unit issued yet another recall, this time due to malfunctioning bottles.
 


Johnson & Johnson issued a recall for OTC infant Tylenol last month due to problems with the bottle design. The new bottle, which was just introduced in November, is malfunctioning. The flow restrictor (at the top of the bottle) has been dislodging and falling into the bottle. There is nothing wrong with the medication itself, and consumers can continue to administer it.
 
In total, the voluntary recall affected 574,000 bottles of grape-flavored Tylenol, which were distributed across the country. Since September 2009, Johnson & Johnson’s McNeil Consumer Healthcare unit has issued approximately 25 recalls. McNeil has also been plagued by factory shutdowns for more than a year, leading to revenue losses of over $1 billion.
 
The exact product being recalled is Infants’ Tylenol Oral Suspension (1-ounce bottles), lots BIL0U00, BIL0V00, BIL3500, BJL2D00, BJL2E00, BJL2T00, and BJL2U00. Consumers can apply for a refund at the product recall website.

Ms. Wick is a visiting professor at the University of Connecticut School of Pharmacy and a freelance writer from Virginia.

Related Articles
The University of Pittsburgh will offer a unique Master of Science in Pharmacy Business Administration program through its pharmacy and graduate business schools.
Daniel Kraft, MD, chair of medicine at Singularity University and chair/founder of Exponential Medicine, discusses the technologies that will affect pharmacies most in the future.
Anne Burns RPh Vice President of Professional Affairs at the American Pharmacists Association talks how the pharmacist's role has evolved.
A virtual clinic launched by 1-800-Pharmacy and the Independent Pharmacy Cooperative aims to assist pharmacists at independent community pharmacies.
Latest Issues
$auto_registration$